Reducing Diabetes Risk Factors in American Indian Children: Tribal Turning Point (TTP)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03573856 |
|
Recruitment Status :
Recruiting
First Posted : June 29, 2018
Last Update Posted : October 27, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Overweight/Obesity | Behavioral: Active Living Other: Health and Safety | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 360 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Investigator) |
| Primary Purpose: | Prevention |
| Official Title: | Reducing Diabetes Risk Factors in American Indian Children: Tribal Turning Point |
| Actual Study Start Date : | July 1, 2018 |
| Estimated Primary Completion Date : | September 2023 |
| Estimated Study Completion Date : | September 2023 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: Active Living
Three component behavioral intervention consisting of group-based classes, individual motivational interviewing-based sessions, and resource toolbox
|
Behavioral: Active Living
Participants will be provided with education and support for diet and lifestyle modification related to healthy eating and active living. |
|
Placebo Comparator: Health and Safety
One component health and safety program consisting of group classes
|
Other: Health and Safety
Participants will be provided with education related to general health and safety topics. |
- Change from 0 to 12 months in Body Mass Index (BMI) [ Time Frame: 12 months ]
- Change from 0 to 12 months in fasting insulin [ Time Frame: 12 months ]
- Change from 0 to 12 months in BMI z-score [ Time Frame: 12 months ]
- Change from 0 to 12 months in waist circumference [ Time Frame: 12 months ]
- Change from 0 to 12 months in hemoglobin A1c [ Time Frame: 12 months ]
- Change from 0 to 12 months in fasting glucose [ Time Frame: 12 months ]
- Change from 0 to 12 months in fruit/vegetable intake [ Time Frame: 12 months ]Proportion consuming 5+ servings of fruits/vegetables daily
- Change from 0 to 12 months in physical activity [ Time Frame: 12 months ]Proportion engaging in 1+ hour of moderate-vigorous physical activity daily
- Change from 0 to 12 months in screen time [ Time Frame: 12 months ]Proportion watching 2 hours or less of screen time daily
- Change from 0 to 12 months in sugary beverage intake [ Time Frame: 12 months ]Proportion consuming 0 servings of sugary beverages daily
- Participant engagement [ Time Frame: 12 months ]Qualitative factors related to participant engagement
- Program implementation [ Time Frame: 12 months ]Qualitative factors related to program implementation
- Potential for sustained delivery [ Time Frame: 12 months ]Qualitative factors related to potential for sustained delivery
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 7 Years to 10 Years (Child) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- self-identify as American Indian
- BMI >=85th percentile for age and sex
- have at least one parent/primary caregiver (parent) willing to actively participate
Exclusion Criteria:
- diabetes
- any serious youth/parent health concerns that would interfere with participation
- plans to move out of the area during the study period
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03573856
| Contact: Katherine Sauder, PhD | 720-717-1216 | katherine.sauder@ucdenver.edu | |
| Contact: Dana M Dabelea, MD; PhD | 303-724-4414 | dana.dabelea@ucdenver.edu |
| United States, Colorado | |
| Childrens Hospital Colorado | Recruiting |
| Aurora, Colorado, United States, 80045 | |
| Contact: Katherine A Sauder, PhD | |
| Principal Investigator: | Katherine Sauder, PhD | University of Colorado, Denver |
| Responsible Party: | University of Colorado, Denver |
| ClinicalTrials.gov Identifier: | NCT03573856 |
| Other Study ID Numbers: |
17-1306 R01DK115434 ( U.S. NIH Grant/Contract ) |
| First Posted: | June 29, 2018 Key Record Dates |
| Last Update Posted: | October 27, 2021 |
| Last Verified: | October 2021 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Overweight Body Weight |

